Structure

InChI Key XCPGHVQEEXUHNC-UHFFFAOYSA-N
Smile COc1cc(NS(C)(=O)=O)ccc1Nc1c2ccccc2nc2ccccc12
InChI
InChI=1S/C21H19N3O3S/c1-27-20-13-14(24-28(2,25)26)11-12-19(20)23-21-15-7-3-5-9-17(15)22-18-10-6-4-8-16(18)21/h3-13,24H,1-2H3,(H,22,23)

Physicochemical Descriptors

Property Name Value
Molecular Formula C21H19N3O3S
Molecular Weight 393.47
AlogP 4.51
Hydrogen Bond Acceptor 5.0
Hydrogen Bond Donor 2.0
Number of Rotational Bond 5.0
Polar Surface Area 80.32
Molecular species NEUTRAL
Aromatic Rings 4.0
Heavy Atoms 28.0

Pharmacology

Action Mechanism of Action Reference
INHIBITOR DNA topoisomerase II inhibitor PubMed PubMed PubMed PubMed PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Leukemia 3 D007938 ClinicalTrials
Leukemia, Myeloid, Acute 3 D015470 ClinicalTrials
Myelodysplastic Syndromes 3 D009190 ClinicalTrials

Related Entries

Scaffolds

Cross References

Resources Reference
CAS NUMBER 51264-14-3
ChEBI 2687
ChEMBL CHEMBL43
DrugBank DB00276
DrugCentral 203
EPA CompTox DTXSID4022604
FDA SRS 00DPD30SOY
Human Metabolome Database HMDB0014421
KEGG C01553
PDB ASW
PharmGKB PA10309
PubChem 2179
SureChEMBL SCHEMBL4047
ZINC ZINC000003812923